Containment will always be needed to protect payloads during transportation. While it is important to the protection of the value of the payload, it has no environmental benefit. It is important for organizations to carefully consider the impact of their containment, packaging, and shipping decisions, especially when high volumes of transactions are involved. Read more about how a reusable logistical approach as opposed to a single-use shipper can considerably reduce the environmental impacts of transporting thermally protected payloads.
The costs are high when leakage occurs during steps that are critical to patient safety. Read how the robustness of Sartorius films makes them safe and easy to use for all process steps and applications.
Learn how streamlining operations and using a process called Late Stage Customization you can significantly reduce costs to ensure a more efficient, flexible supply chain.
For a host of reasons, auto-injectors are becoming biopharma companies’ delivery method of choice for commercial use and late-stage clinical trials. Auto-injectors ensure that the prescribed dose of medication is delivered fully and completely,making it easier to track compliance in clinical trials.
Commercial packaging provider addresses client needs of bringing more advanced medicines and orphan drugs to the market.
Almac explains how, through the use of the Hapa BlisterJet printer, they are able to maximize the stock flexibility of their clients’ valuable orphan drug products, meaning they can distribute product more efficiently between different European countries.
Though the timelines may vary, across the globe more and more countries are requiring product identifiers and serialization of prescription drugs — right down to individual salable units.
This video highlights Almac’s world-class Charnwood campus facilities which currently have over 1,500m2 of readily available GMP floor space that can be customized to suit the specific needs of their client partners.
A pharma company recognized the importance of partnering with an experienced, full service CMO to guide them through the complexities and toward the successful launch of their product.
Increased regulatory scrutiny and exciting new analytical technologies have altered the landscape of container closure integrity testing. In order to provide guidance to this new environment the US Pharmacopoeia revised Chapter <1207> Sterile Product Package Integrity. View this webinar recording to learn about the new guidelines and how they will impact your approach to sterile product package integrity.
|
|
|
|
|
|
|
|
|